Heritability studies are essential for defining genetic influences on disease risk and trait variability. Polubriaginof et al. show how massive amounts of data contained in electronic health records can be used for heritability studies on hundreds of phenotypes. Mining emergency contact information with comparison to existing gold standards showcases the broad utility of the approach.
Before the modern genome era, the most powerful of heritability studies had been twin studies that carefully evaluated specific diseases or traits. However, these studies are costly, are limited with respect to the number of conditions and ancestries that can be assessed, can be confounded by shared environment, and have often been limited in the sociocultural and ancestral diversity of the populations explored. A more recent advance for assessing heritability has been enabled by the explosion of the genome-wide association study (GWAS) era. One finding from the GWAS era was that small collections of individual SNPs typically explained little of the heritability of common disease. However, application of linear mixed-modeling approaches applied across dense genome-wide data collected on unrelated individuals has provided assessments of heritability or genetic liability comparable to familybased approaches (Lee et al., 2011) . As the number of genome-wide studies has grown, robust assessments of genetic heritability have been derived for a variety of conditions. The largest of these studies are now nearing a million individuals in many cohorts (Marouli et al., 2017) . Often, the heritability estimated for common diseases from population data has mirrored that from twin studies. These cohortbased estimates are less influenced by shared environment but typically only measure additive genetic variance and can miss effects of rare variants, which can have strong effects at times. In this issue of Cell, Polubriaginof et al. (2018) present a new method that can reach an even more massive scale and broad trait coverage: creating pedigrees from electronic health records (EHRs) for evaluating observed heritability.
The foundation of the approach, called relationship inference from the electronic health record (RIFTEHR), is that most clinics and hospitals record emergency contact information for nearly all patients and that many families receive care at the same institution. Latent in this information is the basis for looking at heritability (h 0 2 ). Basic demographics (first and last name, phone number, zip code, and asserted relationship) were used to match emergency contact information to existing patients also receiving care at that healthcare system, and then age and gender appropriately oriented relationships (e.g., the algorithm required a parent to be at least 10 years older than their child). The authors applied their method in three EHR systems from the New York City area to create pedigrees from more than 7.4 million familial relationships. Individual families at one institution had up to 134 members in them. In comparison, the biggest prior single twin study had just over 200,000 people (Mucci et al., 2016) , and a meta-analysis of 2,748 prior twin studies since 1955 accumulated just over 14.5 million people (Polderman et al., 2015) . Furthermore, this approach can easily scale to incorporate many more medical centers. Powerfully, each individual's EHR comprises a robust collection of diseases, treatments, and laboratory values that can also be used for study (Figure 1 ). An important component of introducing any new method is demonstrating its validity compared to accepted standards.
The authors robustly evaluated their method's validity using three complementary approaches: mother-child record linkages recorded in the EHRs, SNP array data to identify familial relationships, and prior twin studies. RIFTEHR had a >92% sensitivity and specificity to identify mother-child relationships compared to those manually recorded during birth at two hospitals. The observed heritability estimates were significantly correlated with expected genetic relatedness using genotype array data. Then, they applied their system to mine EHR data for the largest clinical heritability study performed to date across 500 clinical conditions and laboratory values. Observed heritability estimates were strongly correlated between different institutions, demonstrating that the algorithm produces meaningful results at different sites and is also consistent with prior literature estimates from twin studies where available.
A key enabling aspect of this work is the use of the EHR as a rich, available source of diverse phenotype data. Within the last decade, EHRs have been shown to be powerful tools for genomic investigation, highlighting associations with dozens of diseases and drug response traits and even showing insights into evolutionary biology (Robinson et al., 2018) . A powerful feature of EHR data is the ability to rapidly ascertain a comprehensive collection of clinical phenotypes, thereby enabling ''phenome-wide association studies'' (PheWASs) and analysis of clusters of phenotypes together. A prior PheWAS used SNP-based heritability calculations to guide genetic association studies; however, this study was limited by relying on exome arrays, which do not capture robust variation across the genome and thus underestimated trait heritability (Mosley et al., 2016) . Nonetheless, this prior study, in a modest number of individuals, highlighted several phenotypes with high heritability for which a subsequent GWAS identified novel associated variants. Similarly, by prioritizing conditions over the large and diverse populations in the EHRs, Polubriaginof et al. highlight other conditions for which genomic studies should be performed. Moreover, since the method is relatively easily applied across diverse sites and EHRs, it could provide a tool to assess the variations in heritability among diverse populations, geographies, and social and behavioral determinants of health-important parts of better understanding health disparities.
This study also suggests the possibility of an interesting clinical corollary: that individual patient family histories or family history disease-risk estimates may be improved using methods that provide automated record linkage and then leverage the actual clinical EHR data to identify a prioritized list of the diseases for which one is at risk. Such data could supplement medical family histories, which are notoriously underspecified, not adequately queried by physicians, and not well known to many patients. However, significant privacy concerns would need to be addressed before such data could be used clinically. Potential solutions could include providing for explicit ''consent for sharing'' or calculating disease risk with privacy-preserving approaches.
As with all studies, this study is not without limitations. Like other population studies, these estimates are influenced by environmental and cultural factors. The reported estimates of heritability were typically lower than those from twin studies. Notably, the observed heritability for cystic fibrosis was remarkably low h 0 2 = 0.01; instead, this should be closer to their observed heritability for sickle cell anemia (h 0 2 = 0.97). This error could be influenced by prenatal diagnosis, referral patterns, small family sizes for a rare condition, and infertility of affected cases. Additionally, EHRs can suffer from fragmentation and missing information, which can also underestimate heritability. That said, the authors compared their results to a recent study using the UK Biobank that measured the SNP heritability of 555 self-identified traits and inpatient diagnoses codes (Ge et al., 2017) . The EHRderived heritability estimates were significantly higher than what was reported across the UK Biobank-possibly related to disease underreporting in the UK Biobank, but also potentially reflecting environmental influences in observed heritability studies not present in the purely genetic UK Biobank study. In summary, this study provides an important new method that uses the vast quantity of clinical data in the EHR as a tool to study the heritability of diverse clinical conditions. The authors rigorously tested the approach against known standards, showing it works well compared to accepted standards and across different healthcare systems. Finally, it presents a compendium of heritability across 500 conditions, many of which have never been studied before. The use of emergency contact information from three hospital systems in New York City allowed determination of heritability estimates for hundreds of diseases using patient-provided emergency contact information and demographics from millions of patients. The pedigree in this figure is from the paper. Billing codes and claims data (dichotomous) and laboratory data (continuous values) can be used for heritability studies. Textual data (e.g., clinical notes and reports) were not used in this study but represent a potential future target of this approach for an even richer set of features.
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